Direct determination of dopamine D4 receptors in normal and schizophrenic postmortem brain tissue: A [3H]NGD-94-1 study

Molecular Psychiatry

Volumn 3, Issue 6, 1998, Pages 528-533

  Lahti, R A ^a   Roberts, R C ^a   Cochrane, E V ^b   Primus, R J ^a   Gallager, D W ^b   Conley, R R ^a   Tamminga, C A ^b  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

^b NEUROGEN CORPORATION   (United States)

Author keywords

D4 receptor; Dopamine; Human; Postmortem; Schizophrenia

Indexed keywords

2 PHENYL 4 [4 (2 PYRIMIDINYL) 1 PIPERAZINYLMETHYL]IMIDAZOLE; BRAIN RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT;

ADULT; ARTICLE; AUTOPSY; AUTORADIOGRAPHY; BINDING AFFINITY; BRAIN REGION; CAUDATE NUCLEUS; CELL NUCLEUS MATRIX; CLINICAL ARTICLE; CONTROLLED STUDY; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; ISOTOPE LABELING; MALE; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RECEPTOR DENSITY; SCHIZOPHRENIA; SUBSTANTIA NIGRA;

ADULT; ANTIPSYCHOTIC AGENTS; AUTOPSY; AUTORADIOGRAPHY; DOPAMINE ANTAGONISTS; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPUS; HUMANS; IMIDAZOLES; MALE; ORGAN SPECIFICITY; PYRIMIDINES; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; REFERENCE VALUES; SCHIZOPHRENIA; TRITIUM;

EID: 0031789963     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000423     Document Type: Article

References (29)

1. 4 receptors elevated in schizophrenia. Nature 1993; 3G5: 441-445.
2. 4 receptors in postmortem striatum from patients with schizophrenia. J Neuroscience 1995; 15: 2186-2191.
3. 3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression. Brain Res 1995; 681: 109-116.
4. 4 receptors in drug-treated schizophrenia. Eur JPharmacol 1995; 281: R5-R6.
5. Reynolds GP, Mason SL. Are striatal dopamine D4 receptors increased in schizophrenia? J Neurochem 1994; 63: 1576-1577.
6. 2-type dopamine receptors in postmortem human brain sections from normal and schizophrenic subjects. A'euroreporf 1996; 7: 1945-1948.
7. 3H]NGD 94-1. J Pharmacol Exp Ther 1997; 282: 1020-1027.
8. Tallman JF, Primus RJ, Broderick R, Cornfield L, Meade R, Woodruff K et al. I. NGD 94-1: Identification of a novel, high affinity antagonist at the human dopamine D4 receptor. J Pharmacol Exp Ther 1997; 282: 1010-1019.
9. Civelli O, Bunzow JR, Grandy DK, Zhou Q-Y, Van Toi HMM. Molecular biology of the dopamine receptors. Eur J Pharmacol 1991; 207: 277-286.
10. 125I]epidepride. Brain B.es 1993; G09: 237-243.
11. 2-Family receptor distribution in human postmortem tissue: an autoradiographic study. Neumreport 1995; 6: 2505-2512.
12. 3 receptors on neurotensin mRNA expression in nucleus accumbens. Eur J Neurosci 1994; 6: 1384-1387.
13. 4 receptor antagonist in two models of learning and memory. Soc For Neuroscience Meeting 1995; Abstract 191.12.
14. Burt DR, Creese I, Snyder SH. Antischizophrenia drugs: chronic treatment elevates dopamine receptor binding in brain. Science 1977; 196: 326-328.
15. 4 receptors by 2-fold in rats. Eur J Pharmacol 1995; 289: 67-72.
16. Meador-Woodruff JH, Grandy DK, Van Toi HMM, Damask SP, Little KY et al. Dopamine receptor gene expression in the human medial temporal lobe. Neuropsychopharmacology 1994; 10: 239-248.
17. Meador-Woodruff JH, Damask SJ, Wang J, Haroutunian V, Davis KL, Watson SJ. Dopamine receptor mRNA expression in human striatum and neocortex. Neuropsychopharmacology 1996; 15: 1729.
18. Matsumoto M, Hidaka K, Tada S, Tasaki Y, Yamaguchi T. Fulllength cDNA cloning and distribution of human dopamine D4 receptor. Mol Brain Res 1995; 20: 157-162.
19. Mrzljak L, Bergson C, Pappy M, Huff R, Levenson R, GoldmanRakic PS. Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. Nature 1996; 381: 245-248.
20. Stefanis NC, Bresnick JN, Kenvin RW, Schofield WN, McAllister G. Elevation of D-4 dopamine receptor mRNA in postmortem schizophrenic brain. Mol Brain Res 1998; 53: 112-119.
21. Ariano MA, Wang J, Noble KL, Larson ER, Sibley DR. Cellular distribution of the rat D-4 dopamine receptor protein in the CNS using anti-receptor antisera. Brain Res 1997; 752: 26-34.
22. Akil M, Lewis DA. The catecholaminergic innervation of the human entorhinal and prefrontal cortices: alterations in schizophrenia. Schizophrenia Res 1995; 15: 25.
23. Falkai P, Bogerts B, Rozumek M. Cell loss and volume reduction in the entorhinal cortex of schizophrenics. Biol Psychiatry 1988; 24: 515-521.
24. Bruton CJ, Crow TJ, Frith CD, Johnstone ED, Owens DGC, Roberts GW. Schizophrenia and the brain: a prospective clinico-neuropathological study. Psychol Medicine 1990; 20: 285-304.
25. Arnold SE, Hyman BT, Van Hoesen GW, Damasio AR. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch Gen Psychiatry 1991; 48: 625-632.
26. Jeste D, Lohr JB. Hippocampal pathological findings in schizophrenia. Arch Gen Psychiatry 1989; 46: 1019-1024.
27. Tamminga CA, Thanker GK, Buchanan R, Kirkpatrick B, Alphs LD, Chase TN et al. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry 1992; 49: 522-530.
28. Shapiro RM. Review Article. Regional neuropathology in schizophrenia: Where are we? Where are we going? Schizophrenia Res 1993; 10: 187-239.
29. Fargin A, Raymond JR, Lohse MJ, Kobilka BK, Caron MG, Lefkowitz RJ. The genomic clone G-21 which resembles a /3-adrenergic receptor sequence encodes the 5-HT1A receptor. Nature 1988; 335: 358-360.